Join
Live feed
·
INSIDERFilingvia Quantisnow
Aurinia Pharmaceuticals Inc logo

Chief Executive Officer Greenleaf Peter was granted 196,403 shares and covered exercise/tax liability with 100,890 shares, increasing direct ownership by 5% to 1,840,379 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AUPH (Aurinia Pharmaceuticals Inc) and more on Quantisnow.